{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T19:10:03Z","timestamp":1732907403254,"version":"3.30.0"},"reference-count":47,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.3201\/eid3002.230144","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T16:15:44Z","timestamp":1705076144000},"source":"Crossref","is-referenced-by-count":0,"title":["Impact of Meningococcal ACWY Vaccination Program during 2017\u201318 Epidemic, Western Australia, Australia"],"prefix":"10.3201","volume":"30","author":[{"given":"Krist","family":"Ewe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parveen","family":"Fathima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Effler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolien","family":"Giele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3002.230144-202401111117-R1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11910-015-0524-6","article-title":"Invasive meningococcal disease in the 21st century\u2014an update for the clinician.","volume":"15","author":"Dwilow","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"key":"key-10.3201\/eid3002.230144-202401111117-R2","doi-asserted-by":"publisher","first-page":"B3","DOI":"10.1016\/j.vaccine.2011.12.062","article-title":"Meningococcal disease: clinical presentation and sequelae.","volume":"30","author":"Pace","year":"2012","journal-title":"Vaccine"},{"key":"key-10.3201\/eid3002.230144-202401111117-R3","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1080\/21645515.2018.1532248","article-title":"Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies.","volume":"15","author":"Booy","year":"2019","journal-title":"Hum Vaccin Immunother"},{"unstructured":"Australian Government Department of Health. Invasive meningococcal disease 2020 [cited 2020 Nov 19]. https:\/\/www1.health.gov.au\/internet\/main\/publishing.nsf\/Content\/ohp-meningococcal-W.htm","key":"key-10.3201\/eid3002.230144-202401111117-R4"},{"key":"key-10.3201\/eid3002.230144-202401111117-R5","first-page":"E454","article-title":"Rise in invasive serogroup W meningococcal disease in Australia 2013-2015.","volume":"40","author":"Martin","year":"2016","journal-title":"Commun Dis Intell Q Rep"},{"key":"key-10.3201\/eid3002.230144-202401111117-R6","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1017\/S0950268819002152","article-title":"Atypical presentation of invasive meningococcal disease caused by serogroup W meningococci.","volume":"148","author":"Stinson","year":"2020","journal-title":"Epidemiol Infect"},{"key":"key-10.3201\/eid3002.230144-202401111117-R7","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/cid\/ciu881","article-title":"Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales.","volume":"60","author":"Ladhani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid3002.230144-202401111117-R8","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3390\/microorganisms8101521","article-title":"Vaccines against meningococcal diseases.","volume":"8","author":"Pizza","year":"2020","journal-title":"Microorganisms"},{"unstructured":"National Centre from Immunisation Research and Surveillance. Significant events in meningococcal vaccination practice in Australia [cited 2023 Nov 27]. https:\/\/ncirs.org.au\/health-professionals\/history-immunisation-australia","key":"key-10.3201\/eid3002.230144-202401111117-R9"},{"key":"key-10.3201\/eid3002.230144-202401111117-R10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijid.2018.05.022","article-title":"Meningococcal carriage in high-risk settings: A systematic review.","volume":"73","author":"Peterson","year":"2018","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid3002.230144-202401111117-R11","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/ije\/22.4.742","article-title":"Estimation of vaccine effectiveness using the screening method.","volume":"22","author":"Farrington","year":"1993","journal-title":"Int J Epidemiol"},{"unstructured":"Australian Bureau of Statistics. National, state and territory population, March 2022 [cited 2022 Oct 12]. https:\/\/www.abs.gov.au\/statistics\/people\/population\/national-state-and-territory-population\/mar-2022","key":"key-10.3201\/eid3002.230144-202401111117-R12"},{"key":"key-10.3201\/eid3002.230144-202401111117-R13","doi-asserted-by":"publisher","first-page":"e44102","DOI":"10.1371\/journal.pone.0044102","article-title":"Laboratory-based surveillance of Neisseria meningitidis isolates from disease cases in Latin American and Caribbean countries, SIREVA II 2006-2010.","volume":"7","author":"Ibarz-Pav\u00f3n","year":"2012","journal-title":"PLoS One"},{"key":"key-10.3201\/eid3002.230144-202401111117-R14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3201\/eid2102.140746","article-title":"Neisseria meningitidis ST-11 clonal complex, Chile 2012.","volume":"21","author":"Araya","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid3002.230144-202401111117-R15","doi-asserted-by":"publisher","first-page":"e0116725","DOI":"10.1371\/journal.pone.0116725","article-title":"Incidence, carriage and case-carrier ratios for meningococcal meningitis in the African meningitis belt: a systematic review and meta-analysis.","volume":"10","author":"Koutangni","year":"2015","journal-title":"PLoS One"},{"key":"key-10.3201\/eid3002.230144-202401111117-R16","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3201\/eid2003.131407","article-title":"Neisseria meningitidis serogroup W, Burkina Faso, 2012.","volume":"20","author":"MacNeil","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid3002.230144-202401111117-R17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/5584_2015_5006","article-title":"Imported and Indigenous cases of Invasive Meningocococcal Disease W:P1.5,2:F1-1: ST-11 in migrants\u2019 reception centers. Italy, June-November 2014.","volume":"897","author":"Stefanelli","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"key-10.3201\/eid3002.230144-202401111117-R18","doi-asserted-by":"publisher","first-page":"1800245","DOI":"10.2807\/1560-7917.ES.2019.24.14.1800245","article-title":"Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017.","volume":"24","author":"Krone","year":"2019","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid3002.230144-202401111117-R19","doi-asserted-by":"publisher","first-page":"e473","DOI":"10.1016\/S2468-2667(17)30157-3","article-title":"Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study.","volume":"2","author":"Knol","year":"2017","journal-title":"Lancet Public Health"},{"key":"key-10.3201\/eid3002.230144-202401111117-R20","doi-asserted-by":"publisher","first-page":"e01409","DOI":"10.1128\/JCM.01409-17","article-title":"Whole-genome sequencing of emerging invasive Neisseria meningitidis serogroup W in Sweden.","volume":"56","author":"Eriksson","year":"2018","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid3002.230144-202401111117-R21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1071\/NB07047","article-title":"Aboriginal and Torres Strait Islander peoples at higher risk of invasive meningococcal disease in NSW.","volume":"19","author":"Massey","year":"2008","journal-title":"N S W Public Health Bull"},{"key":"key-10.3201\/eid3002.230144-202401111117-R22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5694\/mja16.01340","article-title":"Epidemiology of invasive meningococcal B disease in Australia, 1999-2015: priority populations for vaccination.","volume":"207","author":"Archer","year":"2017","journal-title":"Med J Aust"},{"key":"key-10.3201\/eid3002.230144-202401111117-R23","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3201\/eid2607.181941","article-title":"Case manifestations and public health response for outbreak of meningococcal W disease, Central Australia, 2017.","volume":"26","author":"Sudbury","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid3002.230144-202401111117-R24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/01.inf.0000202065.03366.0c","article-title":"Population-based analysis of meningococcal disease mortality in the United States: 1990-2002.","volume":"25","author":"Sharip","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid3002.230144-202401111117-R25","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.vaccine.2005.01.050","article-title":"New Zealand\u2019s epidemic of meningococcal disease described using molecular analysis: implications for vaccine delivery.","volume":"23","author":"Dyet","year":"2005","journal-title":"Vaccine"},{"unstructured":"Australian Institute of Health and Welfare. Indigenous housing: Australian Government; 2019 [cited 2021 May 9]. https:\/\/www.aihw.gov.au\/reports\/australias-welfare\/indigenous-housing","key":"key-10.3201\/eid3002.230144-202401111117-R26"},{"unstructured":"Australian Institute of Health and Welfare. Profile of First Nations people [cited 2021 Jan 8]. https:\/\/www.aihw.gov.au\/reports\/australias-welfare\/profile-of-indigenous-australians","key":"key-10.3201\/eid3002.230144-202401111117-R27"},{"key":"key-10.3201\/eid3002.230144-202401111117-R28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1046\/j.1440-1754.1999.t01-1-00337.x","article-title":"Invasive meningococcal infection in Western Australia.","volume":"35","author":"Olesch","year":"1999","journal-title":"J Paediatr Child Health"},{"unstructured":"Australian Institute of Health and Welfare. Historical coverage data tables for Aboriginal and Torres Strait Islander children [cited 2023 Sep 25]. https:\/\/www.health.gov.au\/topics\/immunisation\/immunisation-data\/childhood-immunisation-coverage\/historical-coverage-data-tables-for-aboriginal-and-torres-strait-islander-children","key":"key-10.3201\/eid3002.230144-202401111117-R29"},{"key":"key-10.3201\/eid3002.230144-202401111117-R30","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/S0140-6736(00)03502-9","article-title":"Serogroup W135 meningococcal disease in Hajj pilgrims.","volume":"356","author":"Taha","year":"2000","journal-title":"Lancet"},{"key":"key-10.3201\/eid3002.230144-202401111117-R31","first-page":"43","article-title":"Australian Meningococcal Surveillance Programme annual report, 2017.","volume":"2019","author":"Lahra","year":"2018","journal-title":"Commun Dis Intell"},{"key":"key-10.3201\/eid3002.230144-202401111117-R32","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jinf.2015.07.007","article-title":"Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage.","volume":"71","author":"Lucidarme","year":"2015","journal-title":"J Infect"},{"key":"key-10.3201\/eid3002.230144-202401111117-R33","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.ebiom.2015.09.007","article-title":"Genomic epidemiology of hypervirulent serogroup W, ST-11 Neisseria meningitidis.","volume":"2","author":"Mustapha","year":"2015","journal-title":"EBioMedicine"},{"key":"key-10.3201\/eid3002.230144-202401111117-R34","doi-asserted-by":"publisher","first-page":"e0282971","DOI":"10.1371\/journal.pone.0282971","article-title":"Whole genome analysis of Neisseria meningitidis isolates from invasive meningococcal disease collected in the Czech Republic over 28 years (1993-2020).","volume":"18","author":"Honskus","year":"2023","journal-title":"PLoS One"},{"key":"key-10.3201\/eid3002.230144-202401111117-R35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijid.2018.01.019","article-title":"Whole genome typing of the recently emerged Canadian serogroup W Neisseria meningitidis sequence type 11 clonal complex isolates associated with invasive meningococcal disease.","volume":"69","author":"Tsang","year":"2018","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid3002.230144-202401111117-R36","doi-asserted-by":"publisher","first-page":"e220118","DOI":"10.1590\/0074-02760220118","article-title":"Characterisation of Neisseria meningitidis cc11\/ET-15 variant by whole genome sequencing.","volume":"117","author":"Santos","year":"2022","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"key-10.3201\/eid3002.230144-202401111117-R37","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1016\/j.vaccine.2019.04.020","article-title":"Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis.","volume":"37","author":"Wang","year":"2019","journal-title":"Vaccine"},{"key":"key-10.3201\/eid3002.230144-202401111117-R38","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1017\/S0950268817000929","article-title":"Clinical presentation of invasive disease caused by Neisseria meningitidis serogroup Y in Sweden, 1995 to 2012.","volume":"145","author":"S\u00e4ll","year":"2017","journal-title":"Epidemiol Infect"},{"key":"key-10.3201\/eid3002.230144-202401111117-R39","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/aje\/kwm147","article-title":"A prospective study of the effectiveness of the New Zealand meningococcal B vaccine.","volume":"166","author":"Kelly","year":"2007","journal-title":"Am J Epidemiol"},{"unstructured":"National Meningitis Association. Serogroup B meningococcal disease [cited 2021 May 9]. https:\/\/nmaus.org\/nma-disease-prevention-information\/serogroup-b-meningococcal-disease","key":"key-10.3201\/eid3002.230144-202401111117-R40"},{"key":"key-10.3201\/eid3002.230144-202401111117-R41","doi-asserted-by":"publisher","first-page":"B40","DOI":"10.1016\/j.vaccine.2011.12.073","article-title":"Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience.","volume":"30","author":"Djingarey","year":"2012","journal-title":"Vaccine"},{"key":"key-10.3201\/eid3002.230144-202401111117-R42","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1377\/hlthaff.2011.0328","article-title":"Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine.","volume":"30","author":"LaForce","year":"2011","journal-title":"Health Aff (Millwood)"},{"key":"key-10.3201\/eid3002.230144-202401111117-R43","doi-asserted-by":"publisher","first-page":"e0187466","DOI":"10.1371\/journal.pone.0187466","article-title":"Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.","volume":"12","author":"Diallo","year":"2017","journal-title":"PLoS One"},{"key":"key-10.3201\/eid3002.230144-202401111117-R44","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1016\/S0140-6736(16)31921-3","article-title":"Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study.","volume":"388","author":"Parikh","year":"2016","journal-title":"Lancet"},{"key":"key-10.3201\/eid3002.230144-202401111117-R45","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/jpc.12030","article-title":"Factors determining vaccine uptake in Western Australian adolescents.","volume":"49","author":"Mak","year":"2013","journal-title":"J Paediatr Child Health"},{"key":"key-10.3201\/eid3002.230144-202401111117-R46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/s13104-020-05241-9","article-title":"Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease.","volume":"13","author":"Taha","year":"2020","journal-title":"BMC Res Notes"},{"key":"key-10.3201\/eid3002.230144-202401111117-R47","doi-asserted-by":"publisher","first-page":"e360","DOI":"10.1016\/S2589-7500(21)00077-7","article-title":"Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data.","volume":"3","author":"Brueggemann","year":"2021","journal-title":"Lancet Digit Health"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/30\/2\/23-0144_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T18:37:07Z","timestamp":1732905427000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/30\/2\/23-0144_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3002.230144","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"type":"print","value":"1080-6040"},{"type":"electronic","value":"1080-6059"}],"subject":[],"published":{"date-parts":[[2024,2]]}}}